JP2010534707A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010534707A5 JP2010534707A5 JP2010518632A JP2010518632A JP2010534707A5 JP 2010534707 A5 JP2010534707 A5 JP 2010534707A5 JP 2010518632 A JP2010518632 A JP 2010518632A JP 2010518632 A JP2010518632 A JP 2010518632A JP 2010534707 A5 JP2010534707 A5 JP 2010534707A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- carbonyl
- aminocarbonyl
- group
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 C 1-3 -alkyl Chemical group 0.000 claims description 99
- 150000001875 compounds Chemical class 0.000 claims description 31
- 229910052799 carbon Inorganic materials 0.000 claims description 24
- 150000003839 salts Chemical class 0.000 claims description 24
- ABNXTRWXTXTEEL-UHFFFAOYSA-N [(1-acetyl-2,3-dihydroindol-5-yl)-(3,5-dichlorophenyl)sulfonylamino]methylphosphonic acid Chemical compound C=1C=C2N(C(=O)C)CCC2=CC=1N(CP(O)(O)=O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 ABNXTRWXTXTEEL-UHFFFAOYSA-N 0.000 claims description 23
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 20
- 125000000623 heterocyclic group Chemical group 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 16
- 229910052757 nitrogen Inorganic materials 0.000 claims description 16
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 14
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 10
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 10
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 8
- KNZJIFJSBZPTHP-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-(1-methyl-2-oxo-3h-indol-5-yl)amino]methylphosphonic acid Chemical compound C=1C=C2N(C)C(=O)CC2=CC=1N(CP(O)(O)=O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 KNZJIFJSBZPTHP-UHFFFAOYSA-N 0.000 claims description 8
- FKLRVERGNRYSIS-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-(2-oxo-1,3-dihydroindol-5-yl)amino]methylphosphonic acid Chemical compound C=1C=C2NC(=O)CC2=CC=1N(CP(O)(=O)O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 FKLRVERGNRYSIS-UHFFFAOYSA-N 0.000 claims description 8
- 125000005100 aryl amino carbonyl group Chemical group 0.000 claims description 8
- 125000003118 aryl group Chemical group 0.000 claims description 8
- 229910052801 chlorine Inorganic materials 0.000 claims description 8
- 239000000460 chlorine Substances 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 8
- 239000008194 pharmaceutical composition Substances 0.000 claims description 8
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims description 8
- 125000006563 (C1-3) alkylaminocarbonyl group Chemical group 0.000 claims description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 6
- 229910052794 bromium Inorganic materials 0.000 claims description 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 6
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 6
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims description 6
- 125000006594 (C1-C3) alkylsulfony group Chemical group 0.000 claims description 4
- 125000006698 (C1-C3) dialkylamino group Chemical group 0.000 claims description 4
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims description 4
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 4
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 4
- 150000001721 carbon Chemical group 0.000 claims description 4
- 239000000969 carrier Substances 0.000 claims description 4
- 125000004122 cyclic group Chemical group 0.000 claims description 4
- 125000006576 di-(C1-C3-alkyl)-aminocarbonyl group Chemical group 0.000 claims description 4
- 239000003085 diluting agent Substances 0.000 claims description 4
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 4
- 150000007522 mineralic acids Chemical class 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 125000006559 (C1-C3) alkylamino group Chemical group 0.000 claims description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 2
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims description 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 2
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 2
- CVPZOFXOSLQKJX-UHFFFAOYSA-N CC(=O)N1CCc2cc(ccc12)N(CC(OCOC(=O)C(C)(C)C)(O[PH2]=O)OC(=O)C(C)(C)C)S(=O)(=O)c1cc(Cl)cc(Cl)c1 Chemical compound CC(=O)N1CCc2cc(ccc12)N(CC(OCOC(=O)C(C)(C)C)(O[PH2]=O)OC(=O)C(C)(C)C)S(=O)(=O)c1cc(Cl)cc(Cl)c1 CVPZOFXOSLQKJX-UHFFFAOYSA-N 0.000 claims description 2
- 229920001774 Perfluoroether Polymers 0.000 claims description 2
- MLEJQLCMMMYJDJ-UHFFFAOYSA-N [(3,5-dichlorophenyl)sulfonyl-[1-(methylcarbamoyl)-2,3-dihydroindol-5-yl]amino]methylphosphonic acid Chemical compound C=1C=C2N(C(=O)NC)CCC2=CC=1N(CP(O)(O)=O)S(=O)(=O)C1=CC(Cl)=CC(Cl)=C1 MLEJQLCMMMYJDJ-UHFFFAOYSA-N 0.000 claims description 2
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000004458 methylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])[H] 0.000 claims description 2
- 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 claims description 2
- 125000003386 piperidinyl group Chemical group 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 239000013543 active substance Substances 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000003708 ampul Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical group C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102007035334A DE102007035334A1 (de) | 2007-07-27 | 2007-07-27 | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| PCT/EP2008/059807 WO2009016119A1 (en) | 2007-07-27 | 2008-07-25 | Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type i and ii diabetes mellitus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010534707A JP2010534707A (ja) | 2010-11-11 |
| JP2010534707A5 true JP2010534707A5 (enExample) | 2011-09-08 |
Family
ID=39847082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010518632A Pending JP2010534707A (ja) | 2007-07-27 | 2008-07-25 | 置換アリールスルホニルアミノメチルホスホン酸誘導体、その製法並びにｉ型及びｉｉ型糖尿病の治療におけるその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8211923B2 (enExample) |
| EP (1) | EP2185572A1 (enExample) |
| JP (1) | JP2010534707A (enExample) |
| CA (1) | CA2694108A1 (enExample) |
| DE (1) | DE102007035334A1 (enExample) |
| WO (1) | WO2009016119A1 (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101779677B1 (ko) | 2005-07-26 | 2017-09-18 | 크나우프 인설레이션, 인크. | 접착제 및 이들로 만들어진 물질 |
| EP2450493B1 (en) | 2007-01-25 | 2024-10-02 | Knauf Insulation SPRL | Mineral fibre board |
| PL2108006T3 (pl) | 2007-01-25 | 2021-04-19 | Knauf Insulation Gmbh | Spoiwa i wytworzone z nich materiały |
| US8501838B2 (en) | 2007-01-25 | 2013-08-06 | Knauf Insulation Sprl | Composite wood board |
| DE102007012284A1 (de) * | 2007-03-16 | 2008-09-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| CA2683706A1 (en) | 2007-04-13 | 2008-10-23 | Knauf Insulation Gmbh | Composite maillard-resole binders |
| DE102007035334A1 (de) | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102007035333A1 (de) * | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| GB0715100D0 (en) | 2007-08-03 | 2007-09-12 | Knauf Insulation Ltd | Binders |
| DE102007042154A1 (de) * | 2007-09-05 | 2009-03-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel |
| US8900495B2 (en) | 2009-08-07 | 2014-12-02 | Knauf Insulation | Molasses binder |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| KR101835899B1 (ko) | 2010-05-07 | 2018-03-07 | 크나우프 인설레이션, 인크. | 탄수화물 결합제 및 이를 이용하여 제조된 물질 |
| PT2566904T (pt) | 2010-05-07 | 2021-08-30 | Knauf Insulation | Ligantes de hidrato de carbono e poliamina e materiais feitos com os mesmos |
| WO2011154368A1 (en) | 2010-06-07 | 2011-12-15 | Knauf Insulation | Fiber products having temperature control additives |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| US20130174758A1 (en) * | 2010-09-17 | 2013-07-11 | Knauf Insulation Gmbh | Organic acid carbohydrate binders and materials made therewith |
| JP5959537B2 (ja) | 2011-01-28 | 2016-08-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 置換ピリジニル−ピリミジン及び医薬としてのその使用 |
| US20140186635A1 (en) | 2011-05-07 | 2014-07-03 | Knauf Insulation | Liquid high solids binder composition |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| GB201206193D0 (en) | 2012-04-05 | 2012-05-23 | Knauf Insulation Ltd | Binders and associated products |
| GB201214734D0 (en) | 2012-08-17 | 2012-10-03 | Knauf Insulation Ltd | Wood board and process for its production |
| US20150315339A1 (en) | 2012-12-05 | 2015-11-05 | Knauf Insulation Sprl | Binder |
| WO2015120252A1 (en) | 2014-02-07 | 2015-08-13 | Knauf Insulation, Llc | Uncured articles with improved shelf-life |
| GB201408909D0 (en) | 2014-05-20 | 2014-07-02 | Knauf Insulation Ltd | Binders |
| GB201412709D0 (en) | 2014-07-17 | 2014-09-03 | Knauf Insulation And Knauf Insulation Ltd | Improved binder compositions and uses thereof |
| GB201517867D0 (en) | 2015-10-09 | 2015-11-25 | Knauf Insulation Ltd | Wood particle boards |
| EP3241830A1 (de) | 2016-05-04 | 2017-11-08 | Bayer CropScience Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
| GB201610063D0 (en) | 2016-06-09 | 2016-07-27 | Knauf Insulation Ltd | Binders |
| CA3031139A1 (en) | 2016-07-19 | 2018-01-25 | Bayer Cropscience Aktiengesellschaft | Condensed bicyclic heterocycle derivatives as pest control agents |
| GB201701569D0 (en) | 2017-01-31 | 2017-03-15 | Knauf Insulation Ltd | Improved binder compositions and uses thereof |
| GB201804908D0 (en) | 2018-03-27 | 2018-05-09 | Knauf Insulation Ltd | Binder compositions and uses thereof |
| GB201804907D0 (en) | 2018-03-27 | 2018-05-09 | Knauf Insulation Ltd | Composite products |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69327572T2 (de) | 1992-05-21 | 2000-06-21 | Otsuka Pharmaceutical Factory, Inc. | Phosphonsäurediester-derivat |
| TW260664B (enExample) | 1993-02-15 | 1995-10-21 | Otsuka Pharma Factory Inc | |
| DE19753522A1 (de) | 1997-12-03 | 1999-06-10 | Boehringer Ingelheim Pharma | Substituierte Indole, ihre Herstellung und ihre Verwendung als Arzneimittel |
| JP2000247949A (ja) | 1999-02-26 | 2000-09-12 | Eisai Co Ltd | スルホンアミド含有インドール化合物 |
| AU4398801A (en) | 2000-03-22 | 2001-10-03 | Banyu Pharmaceutical Co., Ltd. | Sulfur substituted aryldifluoromethylphosphonic acids as ptp-1b inhibitors |
| PE20021091A1 (es) * | 2001-05-25 | 2003-02-04 | Aventis Pharma Gmbh | Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion |
| CN1551766A (zh) * | 2001-09-05 | 2004-12-01 | ������������ʽ���� | 淋巴细胞活化抑制剂和自身免疫性疾病治疗剂 |
| DE10215907A1 (de) | 2002-04-11 | 2003-11-06 | Aventis Pharma Gmbh | Acyl-4-carboxyphenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung |
| US7223796B2 (en) * | 2002-04-11 | 2007-05-29 | Sanofi-Aventis Deutschland Gmbh | Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use |
| JP4374428B2 (ja) | 2002-07-11 | 2009-12-02 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 尿素置換されたおよびウレタン置換されたアシル尿素、それらの製造方法および医薬としてのそれらの使用方法 |
| US7262220B2 (en) * | 2002-07-11 | 2007-08-28 | Sanofi-Aventis Deutschland Gmbh | Urea- and urethane-substituted acylureas, process for their preparation and their use |
| AU2003249937A1 (en) * | 2002-07-12 | 2004-02-02 | Sanofi-Aventis Deutschland Gmbh | Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| WO2004096237A2 (en) * | 2003-04-25 | 2004-11-11 | Gilead Sciences, Inc. | Phosphonate analogs for treating metabolic diseases |
| NZ543482A (en) | 2003-05-21 | 2009-02-28 | Prosidion Ltd | Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase |
| ES2222832B1 (es) * | 2003-07-30 | 2006-02-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
| ES2222827B1 (es) * | 2003-07-30 | 2006-03-01 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 5-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
| ES2222829B1 (es) | 2003-07-30 | 2006-03-01 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 4-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
| EP1513085A1 (en) | 2003-09-08 | 2005-03-09 | Abb Research Ltd. | Method of scheduling maintenance actions |
| JP2005206492A (ja) * | 2004-01-21 | 2005-08-04 | Sankyo Co Ltd | スルホンアミド化合物 |
| EP1632491A1 (en) * | 2004-08-30 | 2006-03-08 | Laboratorios Del Dr. Esteve, S.A. | Substituted indole compounds and their use as 5-HT6 receptor modulators |
| BRPI0515522A (pt) * | 2004-09-21 | 2008-07-29 | Athersys Inc | composto, composição farmacêutica. métodos de inibir a ligação de ligandos endógenos ao receptor crth-2 em uma célula, de tratar, melhorar ou prevenir um distúrbio responsivo à inibição da ligação de ligandos endógenos ao receptor crth-2 em um animal e de preparar um composto, e, kit |
| WO2006052722A1 (en) | 2004-11-09 | 2006-05-18 | Smithkline Beecham Corporation | Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof |
| NZ554783A (en) * | 2004-11-15 | 2010-12-24 | Ceptyr Inc | Protein tyrosine phosphatase inhibitors and methods of use thereof |
| WO2007044729A2 (en) | 2005-10-07 | 2007-04-19 | Exelixis, Inc. | N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors |
| DE102007007751A1 (de) * | 2007-02-16 | 2008-08-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| WO2008103354A2 (en) | 2007-02-20 | 2008-08-28 | Cropsolution, Inc. | Modulators of acetyl-coenzyme a carboxylase and methods of use thereof |
| DE102007012284A1 (de) * | 2007-03-16 | 2008-09-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102007035334A1 (de) | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102007035333A1 (de) | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102007042154A1 (de) | 2007-09-05 | 2009-03-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel |
-
2007
- 2007-07-27 DE DE102007035334A patent/DE102007035334A1/de not_active Withdrawn
-
2008
- 2008-07-25 EP EP08786466A patent/EP2185572A1/en not_active Withdrawn
- 2008-07-25 CA CA2694108A patent/CA2694108A1/en not_active Abandoned
- 2008-07-25 JP JP2010518632A patent/JP2010534707A/ja active Pending
- 2008-07-25 WO PCT/EP2008/059807 patent/WO2009016119A1/en not_active Ceased
- 2008-07-25 US US12/669,979 patent/US8211923B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010534707A5 (enExample) | ||
| JP2010521515A5 (enExample) | ||
| ES2287782T3 (es) | Derivados de n-(heteroaril(piperidin-2-il)metil)benzamida, su preparacion y su aplicacion en terapeutica. | |
| AU703350B2 (en) | Novel n-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands | |
| TW200522933A (en) | Muscarinic acetylcholine receptor antagonists | |
| JP2010534706A5 (enExample) | ||
| ES2781681T3 (es) | Profármacos de ésteres de [3-(1-(1H-imidazol-4-il)etil)-2-metilfenil]-metanol para reducir la presión intraocular | |
| BRPI0822033B1 (pt) | composto ou sal do mesmo, composição farmacêutica, e, uso de um composto ou sal | |
| EP0700385A1 (en) | Novel compounds | |
| CN105051005A (zh) | 环丙胺化合物及其用途 | |
| ES2924104T3 (es) | Compuestos azaindazólicos para su uso en lesiones tendinosas y/o ligamentosas | |
| PT626968E (pt) | Derivados de piperidinilo tiaciclicos | |
| US8487095B2 (en) | Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-iso-propyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms | |
| KR900016175A (ko) | 피페리딘 화합물, 이의 제조방법 및 용도 | |
| TWI254706B (en) | Cyclic amine compounds and pharmaceutical composition containing the same | |
| ES2340855T3 (es) | Modulares de receptores 5-ht perifericos. | |
| ES2800948T3 (es) | Derivados de pirazolo[3,4-c]piridina | |
| CN1040645C (zh) | 具有5-ht4受体拮抗活性的化合物、其制备方法及含有该化合物的药物组合物 | |
| EA003426B1 (ru) | Новые бензолсульфонамидные производные, способ их получения и содержащие их фармацевтические композиции | |
| WO1983000865A1 (fr) | Composes de benzothiazoline | |
| AU5287499A (en) | Use of (S)(-)-amisulpride for the manufacture of a medicament for the treatment of positive, negative, affective or cognitive symptoms of Schizophrenia | |
| JP2006503857A5 (enExample) | ||
| ES2733756T3 (es) | Agentes terapéuticos para el tratamiento de hipertensión ocular | |
| CN1128030A (zh) | 具有中枢神经系统活性的杂环胺 | |
| ES2298386T3 (es) | 1-glicinil-4-(1-metilpiperidin-4-il)piperazinas y -piperidinas como antagonistas del factor xa. |